NASDAQ: BPMC       Blueprint Medicines Corp
Last Price Today's Change   Day's Range   Trading Volume
103.25   -1.38 (1.32%)  101.55 - 107.15  61,738


Avg Volume (4 weeks):393,630
4 Weeks Range:91.39 - 107.15
4 Weeks Price Volatility (%):
52 Weeks Range:43.29 - 107.15
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates BLU-285, which targets KIT Exon 17 mutants and PDGFRa D842V, abnormally active receptor tyrosine kinase mutants that are drivers of cancer and proliferative disorders. Its other drug candidate is BLU 554 FOR Advanced Hepatocellular Carcinoma, and BLU-667 for Ret Mutations, Fusions, and Predicted Resistant Mutants.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

2687  3056  504  3155 

Top 10 Active Counters
 LK 1.38+1.38 
 OAS 0.155-0.014 
 NIO 29.845+2.335 
 NOK 3.285-0.765 
 PINS 67.35+18.10 
 AMTD 39.97-0.85 
 PGNX 4.10-0.425 
 GE 7.568+0.148 
 F 8.092+0.392 
 XOG 0.271-0.062